Skip to main content

and
  1. Article

    Open Access

    TT-232: An Anti-tumour and Anti-inflammatory Peptide Therapeutic in Clinical Development

    TT-232 is a structural derivative of the peptide hormone somatostatin with selective anti-proliferative and anti-inflammatory properties. It has a strong anti-tumour activity both in vitro and in vivo on a wide r...

    György Kéri, Richard Schwab in International Journal of Peptide Research … (2005)

  2. No Access

    Chapter

    Peptidomimetic tyrosine kinase inhibitors induce non apoptotic, Clarke-III type programmed cell death

    György Kéri, László Ôrfi, Gergely Szántó in Peptides Frontiers of Peptide Science (2002)

  3. No Access

    Chapter

    Further Studies of the Signaling Mechanisms of the Antitumor Somatostatin Analogue TT-232

    The somatostatin structural analogue TT-232 is a heptapeptide of a cyclopenta-ring structure: D-Phe-Cys-Tyr-D-Thr-Lys-Cys-Thr-NH2 that was shown to have strong antiproliferative and apoptotic effects on tumor cel...

    Attila Steták, Tibor Vántus, Gyöngyi Bökönyi in Peptides: The Wave of the Future (2001)

  4. No Access

    Chapter

    New Antiproliferative Agents from a Peptidomimetic Library

    It is known that chiral ATP analogue quinazolines show selective Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR TK) inhibitory activity depending on the chirality of the molecule [1]. We have developed...

    László Őrfi, Györgyi Bökönyi, Anikó Horváth in Peptides: The Wave of the Future (2001)

  5. No Access

    Chapter

    HPLC Analysis, Modeling, and Biological Studies of Antiproliferative Heterocyclic Carboxamides

    Reversed phase HPLC and MEKC [1] provide excellent possibilities to measure the hydrophobic properties of compounds, characterizing them directly from the chromatographic retention time. The aim in this respec...

    János Seprõdi, Ferenc Hollósy, Dániel Erõs, László Õrfi in Peptides: The Wave of the Future (2001)

  6. No Access

    Article

    New antitumor leads from a peptidomimetic library

    A parallel combinatorial library of over 1600 compounds has been designed and synthesized for the development of new potential peptidomimetic protein tyrosine kinase (PTK) inhibitor leads. These peptidomimetic...

    László Õrfi, Frigyes Wáczek, István Kövesdi, György Mészáros in Letters in Peptide Science (1999)

  7. No Access

    Article

    New antitumor leads from a peptidomimetic library

    A parallel combinatorial library of over 1600 compounds has been designed and synthesized for the development of new potential peptidomimetic protein tyrosine kinase (PTK) inhibitor leads. These peptidomimetic...

    László Õrfi, Frigyes Wáczek, István Kövesdi, György Mészáros in Letters in Peptide Science (1999)